Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001)
Year: 2019
Type: article
Source: Annals of Oncology
Authors: S. Siena, G. Demetri, R. Doebele, Y. Chae, P. Conkling, I. Garrido-Laguna, P. Garrido, C. Rolfo, D. Sigal, S. Eng, B. Simmons, C. Ye, F. Ciardiello
Institutions: University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Dana-Farber Cancer Institute, Northwestern University, Virginia Oncology Associates, Huntsman Cancer Institute, Hospital Universitario Ramón y Cajal, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Scripps Clinic, Genentech
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2962006731